162. 類天疱瘡（後天性表皮水疱症を含む。） Pemphigoid Clinical trials / Disease details

臨床試験数 : 83 / 薬物数 : 128 - (DrugBank : 51) / 標的遺伝子数 : 33 - 標的パスウェイ数 : 142

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05263505 (ClinicalTrials.gov)	February 21, 2022	16/2/2022	Baricitinib for the Treatment of Ocular Mucous Membrane Pemphigoid	Baricitinib for the Treatment of Ocular Mucous Membrane Pemphigoid	Mucous Membrane Pemphigoid;Cicatrizing Conjunctivitis	Drug: Baricitinib 2 MG [Olumiant];Drug: Methotrexate;Drug: Azathioprine;Drug: Mycophenolate	Washington University School of Medicine	Eli Lilly and Company	Recruiting	18 Years	N/A	All	20	Phase 2	United States
2	NCT00431119 (ClinicalTrials.gov)	October 1997	2/2/2007	Azathioprine or Mycophenolate Mofetil for Bullous Pemphigoid	A Comparison of Oral Methylprednisolone Plus Azathioprineor Mycophenolate Mofetil for the Treatment ...	Bullous Pemphigoid	Drug: Azathioprine or Mycophenolate mofetil	University Hospital Muenster	Hoffmann-La Roche	Completed	18 Years	90 Years	Both	70	Phase 2	Germany

First Previous1Next Last